Bansal Multi Ventures

MOUNJARO KwikPen contains the active ingredient tirzepatide.MOUNJARO KwikPen is a type of medicine called 'GIP and GLP-1 receptor agonists'. In adults, this medicine is used to help treat diabetes. In adults who are overweight or have obesity, this medicine is used to reduce weight or maintain weight loss.

RYBELSUS® (semaglutide) tablets 3mg, 7 mg or 14 mg is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.

• It is not known if RYBELSUS® can be used in people who have had pancreatitis
• RYBELSUS® is not for use in people with type 1 diabetes
• It is not known if RYBELSUS® is safe and effective for use in children under 18 years of age

• Key takeaways:

  • Rybelsus (semaglutide) is an oral medication approved to treat Type 2 diabetes. It contains the same active ingredient as Ozempic and Wegovy. Ozempic is approved for Type 2 diabetes, and Wegovy is approved for chronic weight management.

  • Rybelsus is currently being studied for weight loss in clinical trials. These studies involve higher doses than what's currently approved and available for diabetes. 

  • Results show that an oral semaglutide (Rybelsus) dose of 50 mg results in similar weight loss as Wegovy. Due to these findings, Rybelsus' manufacturer plans to request FDA approval in 2023. If approved for weight loss, it may be marketed under a different brand name.

Dapagliflozin Tablet is an oral medication used to manage type 2 diabetes mellitus by helping control blood sugar levels. It belongs to a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). Dapagliflozin works by preventing the kidneys from reabsorbing glucose into the blood, allowing excess glucose to be excreted through the urine. In addition to blood sugar control, it may also provide cardiovascular and kidney protection. It is sometimes prescribed to treat heart failure and chronic kidney disease. Use under medical supervision, often in combination with diet, exercise, or other diabetes medications.

Dapagliflozin Tablet is an oral medication used to manage type 2 diabetes mellitus by helping control blood sugar levels. It belongs to a class of drugs known as SGLT2 inhibitors (sodium-glucose co-transporter 2 inhibitors). Dapagliflozin works by preventing the kidneys from reabsorbing glucose into the blood, allowing excess glucose to be excreted through the urine. In addition to blood sugar control, it may also provide cardiovascular and kidney protection. It is sometimes prescribed to treat heart failure and chronic kidney disease. Use under medical supervision, often in combination with diet, exercise, or other diabetes medications.